Aptamer Sciences Balance Sheet Health
Financial Health criteria checks 6/6
Aptamer Sciences has a total shareholder equity of ₩13.0B and total debt of ₩8.6B, which brings its debt-to-equity ratio to 66.3%. Its total assets and total liabilities are ₩30.6B and ₩17.6B respectively.
Key information
66.3%
Debt to equity ratio
₩8.61b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩21.58b |
| Equity | ₩12.99b |
| Total liabilities | ₩17.59b |
| Total assets | ₩30.58b |
Financial Position Analysis
Short Term Liabilities: A291650's short term assets (₩23.2B) exceed its short term liabilities (₩15.5B).
Long Term Liabilities: A291650's short term assets (₩23.2B) exceed its long term liabilities (₩2.1B).
Debt to Equity History and Analysis
Debt Level: A291650 has more cash than its total debt.
Reducing Debt: A291650 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A291650 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A291650 has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 24.6% each year.